Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
18–55
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Has mild to moderate hypertension
Has grade 1 or 2 arterial hypertension being treated with a single antihypertensive drug
Has been a nonsmoker and/or has not used nicotine or nicotine-containing products for at least approximately 6 months; or who have discontinued smoking or the use of nicotine/nicotine-containing products for at least approximately 3 months
Is in generally good health
You may not be if
Has a history of clinically significant abnormalities or diseases
Has a history of stroke, chronic seizures, or major neurological disorder
Has a functional disability that can interfere with rising from a sitting position to the standing position
Has any personal or family history of a bleeding or a clotting disorder
Has a history of frequent nose bleeds or has recurrent or active gingivitis
Has a history of cancer
Has a history of clinically significant cardiac disease
Is unable to refrain from or anticipates the use of any medication, including prescription and non-prescription drugs or herbal remedies approximately 2 weeks prior to the administration of study drug
Consumes excessive amounts of alcohol
Consumes excessive amounts of caffeinated beverages per day
Has had major surgery, donated or lost 1 unit of blood or participated in another investigational study within 4 weeks of study
Has a history of significant multiple and/or severe allergies (including latex) to prescription or non-prescription drugs or food
Is currently a regular user of any illicit drugs or has a history of drug abuse within approximately 1 year
Clareo Health | A Multiple Dose Study of MK-3614 (MK-3614-002)
